Network origin in Anne Champsaur first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases
24
| Extinct | Biotechnology | 24 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Anne Champsaur via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Amygdala Neurosciences, Inc.
 Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Doctorate Degree | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Comptroller/Controller/Auditor | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Doctorate Degree Corporate Officer/Principal | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
| TOLERANZIA AB | Biotechnology | Director/Board Member | |
| Juristfirma Louise Katsler Waas AB | Director/Board Member | ||
| Anders Waas AB | Director/Board Member | ||
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Corporate Officer/Principal | |
Iscaff Pharma AB
 Iscaff Pharma AB Miscellaneous Commercial ServicesCommercial Services Iscaff Pharma AB develops platform and drugs for treatment of cancer. It develops a scaffold technology for drug development and treatment of cancer. The firm's products and services include development support; 3D printed scaffolds; licensing of technologies; and diagnostics. The company was founded by Göran Landberg and Anders Torbjörn Ståhlberg and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Chairman | |
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chief Executive Officer | |
| ALZINOVA AB | Pharmaceuticals: Major | Director/Board Member | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Transmed Gothenburg AB
 Transmed Gothenburg AB Miscellaneous Commercial ServicesCommercial Services Transmed Gothenburg AB provides scientific and technical research and development services. The company is based in Gothenburg, Sweden. | Miscellaneous Commercial Services | Chairman | |
Texray AB
 Texray AB Packaged SoftwareTechnology Services Texray AB engages in development of medical technology products. It offers radiation protective textile. The company was founded by Petra Apell and Fredrik Gellerstedt and is headquartered in Göteborg, Sweden. | Packaged Software | Director/Board Member | |
| ECTIN RESEARCH AB | Biotechnology | Director/Board Member | |
Sobrera Pharma AB
 Sobrera Pharma AB Pharmaceuticals: MajorHealth Technology Sobrera Pharma AB is a Swedish pharmaceutical company that manufactures products for patients with alcohol use disorders. The company is based in Gothenburg, Sweden. The CEO of the company is Ann-Charlotte Rosendahl. | Pharmaceuticals: Major | Chairman | |
Sortina pharma AB
 Sortina pharma AB Miscellaneous Commercial ServicesCommercial Services Sortina Pharma AB provides scientific and technical services. The company is based in Gothenburg, Sweden. The Swedish company was founded by Sara Rhost, Göran Landberg. | Miscellaneous Commercial Services | Chairman | |
| Gudna Pharma AB | Director/Board Member | ||
SiMSen Diagnostics AB
 SiMSen Diagnostics AB Medical SpecialtiesHealth Technology SiMSen Diagnostics AB develops diagnostic substances. The company is based in Gothenburg, Sweden. | Medical Specialties | Director/Board Member | |
Implexion Pharma AB
 Implexion Pharma AB Miscellaneous Commercial ServicesCommercial Services Implexion Pharma AB is a Swedish company that focuses on researching and developing drugs. The company is based in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| OligoNova Accelerate AB | Chairman | ||
MIVAC Development AB
 MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Biotechnology | Director/Board Member | |
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Astrea Bioseparations Ltd.
 Astrea Bioseparations Ltd. Medical SpecialtiesHealth Technology Astrea Bioseparations Ltd. develops and manufactures affinity purification technology. It specializes in affinity chromatography and bioseparations, specifically purification of proteins and the elimination of contaminants including pathogens. The company was founded in 1987 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Chief Executive Officer | |
ProMetic BioSciences Ltd.
 ProMetic BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services ProMetic BioSciences Ltd. operates as a biopharmaceutical company. The company was founded by Christopher Robin Low and is headquartered in Laval, Canada. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| Heriot-Watt University | College/University | Undergraduate Degree | |
| Scottish Global Health Foundation | Director/Board Member | ||
The Institute of Chartered Accountants of Scotland
 The Institute of Chartered Accountants of Scotland Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants of Scotland operates as a professional membership organization. The non-profit company is based in Edinburgh, UK. The British company was founded by Janice Margaret Brown and Sundeep Bahanda. The CEO is Bruce Cartwright. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Imanova Ltd.
 Imanova Ltd. BiotechnologyHealth Technology Imanova Ltd. provides research and development solutions in biomarkers. It offers clinical imaging, preclinical imaging, analysis and consultancy, access to academic expertise, and consumer health. The company was founded in 2011 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| Being Digital Ltd. | Director/Board Member | ||
The Institute of Directors (United Kingdom)
 The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Liminal BioSciences Ltd.
 Liminal BioSciences Ltd. BiotechnologyHealth Technology Part of Liminal R & D BioSciences, Inc., Liminal BioSciences Ltd. is a British biopharmaceutical company founded in 2015. The company is based in Comberton, UK. The company is focused on the discovery and development of novel, small molecule drug candidates. | Biotechnology | Director/Board Member | |
Fairhaven Pharmaceuticals, Inc.
 Fairhaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Fairhaven Pharmaceuticals, Inc. engages in the research and development of small molecule antagonists that target chemoattractant and activator of eosinophils, which play a key role in type 2 inflammation-driven diseases. The company was founded on May 4, 2018 and is headquartered in Laval, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| Umea Universitet | College/University | Undergraduate Degree |
Statistics
International
| Sweden | 19 |
| United States | 18 |
| United Kingdom | 9 |
| Canada | 5 |
| France | 2 |
Sectoral
| Health Technology | 29 |
| Commercial Services | 9 |
| Consumer Services | 7 |
| Technology Services | 2 |
Operational
| Director/Board Member | 84 |
| Corporate Officer/Principal | 67 |
| Chief Tech/Sci/R&D Officer | 23 |
| Undergraduate Degree | 19 |
| Independent Dir/Board Member | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Cam Gallagher | 24 |
| R. Greer | 23 |
| Anders Waas | 21 |
| Thomas Shenk | 21 |
| Joseph M. Davie | 17 |
| Bruce Philip Pritchard | 15 |
| Kenneth F. Boehm | 12 |
| Hsiao Lieu | 11 |
| Christopher Chai | 10 |
| Louis Yu | 10 |
| Peter M. Strumph | 9 |
| Colin Hislop | 9 |
| Andrew Wolff | 8 |
| Markus Jerling | 8 |
| Karin Walker | 8 |
- Stock Market
- Insiders
- Anne Champsaur
- Company connections